Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

To learn more about the effects of dietary interventions after early breast cancer treatment and the current gaps that exist in systemic reviews that assess those effects, Dr. Matt Birnholz sat down with Dr. Daniela Rosa at the 2019 San Antonio Breast Cancer Symposium.

Ms. Marina Kaplan's inspiring life history as an "outlier survivor" as she put it for having achieved remission from triple-negative breast cancer over six years ago was helped by numerous cutting-edge clinical trials made accessible to her. But the experience as a study subject exposed her to systemic barriers confronting breast cancer patients everywhere, compelling her to reprise her epidemiology career expertise in conducting a study looking for novel solutions, as she shares with Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Considering there’s little known about the breast microenvironment during pregnancy and whether this plays into future breast cancer risk, Dr. Lauren Nye's team examined whether omega 3 supplements as potential non-teratogenic chemoprevention agents could accentuate the protective changes on breast cancer risk that occur with hormonal fluctuations during pregnancy. And Dr. Matt Birnholz was there at the 2019 San Antonio Breast Cancer Symposium to catch up with Dr. Nye about this study.

Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Amid the expanding noninvasive prenatal testing (NIPT) options, Dr. Liza Kunz joins Dr. Jennifer Caudle to discuss what differentiates genome-wide NIPT from other options, how it works, and its limitations and potential benefits.

Under the CDC’s guidelines for providing quality contraceptive counseling, there are several important questions healthcare providers can ask their patients. That’s why Dr. Jan Shephard sits down with Erica, who provides a patient perspective on an effective contraceptive dialogue.

References

1. Gavin L et al. Providing quality family planning services: Recommendations of CDC and the U.S. Office of Population Affairs. MMWR Morb Mortal Wkly Rep. 2014;63:1‒54.
2. World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2018 update). Baltimore and Geneva: CCP and WHO, 2018.

US-XPL-00832 10/19

Copyright © 2019 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.

Tune in as Dr. Matt Birnholz talks with Thanos Kosmidis, the founder and CEO of Care Across, about the company’s new poster presentation on breast cancer patients’ quality of life at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

At the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Matt Birnholz caught up with Kelly Scheu, a nurse practitioner specializing in breast oncology at the University of Michigan, who shared how her spirituality and medical expertise of 27 years in the oncology field blend to enhance breast cancer care.

Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.